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Abstract 
Background: Oxygenation-sensitive cardiovascular magnetic resonance imaging (OS-CMR) is 
an emerging technique that can monitor changes in myocardial oxygenation in vivo. Obstructive 
sleep apnea syndrome (OSAS) is associated with endothelial and microcirculatory dysfunction 
and increased cardiovascular morbidity and mortality. Little is known about myocardial 
responses to apnea in patients with OSAS.  
We hypothesized that the coronary vascular response to hyperventilation and long breath-hold is 
diminished in patients with OSAS when compared to healthy volunteers. 
Methods: Twenty-nine OSAS patients and 36 healthy volunteers were prospectively enrolled. 
All CMR scans were performed on a clinical 3T system. Participants performed a breathing 
maneuver with 60 seconds of hyperventilation followed by a maximal breath-hold. During the 
breath-hold, OS-CMR images were continuously acquired and signal intensity changes were 
measured by a blinded reader.  
Results: Patients with OSAS were older than healthy volunteers (p<0.01) and presented more co-
morbidities; 66% were currently treated with nocturnal positive airway pressure. Compared to 
healthy participants, the expected increase of myocardial oxygenation during the first 15 seconds 
of the breath-hold was significantly lower in patients with OSAS (2.6±8.3% vs. 6.7±5.6% 
p<0.05), and remained reduced at all time points during the breath-hold. Importantly this result 
was mainly driven by patients under continuous positive airway pressure (CPAP), suggesting that 
CPAP might have a greater impact on increase of myocardial oxygenation rather than OSAS 
itself. 
Conclusions: The myocardial vascular response to combined breathing maneuvers of 
hyperventilation followed by voluntary apnea is blunted in patients with obstructive sleep apnea. 
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Clinical studies should now further define the clinical role of oxygenation-sensitive CMR in 
patients with respiratory disorders.  
Montreal Heart Institute, study 12-1372   
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Introduction 
Obstructive sleep apnea syndrome (OSAS) is a common condition affecting at least 10% of the 
general population [1]. OSAS, characterized by recurrent upper airway collapse during sleep with 
subsequent functional apnea, is associated with significant morbidity [2], especially 
cardiovascular disease and mortality [3]. However, little is known in regard to the impact of 
apnea on coronary vascular function in these patients. On one hand, various physiological 
pathways including endothelial function are impaired in patients with OSAS [4], which could 
worsen microvascular function and lead to tissue injury. On the other hand, the frequent exposure 
to transient hypoxia may lead to ischemic preconditioning, an effective mechanism of 
cardioprotection during ischemia [5]. These pathophysiological considerations are of crucial 
importance when considering the recent warnings as regards the SERVE-HF study 
(NCT00733343) [6]. In this clinical trial, patients with both stable heart failure (HF) with reduced 
left ventricular ejection fraction (LVEF) and predominantly central apnea were treated by 
adaptive servo-ventilation. Surprisingly, a warning on the mortality in the treated patients led 
recently to withdraw the ventilation. Even if the patients considered in the present study are 
different (patients with HF were excluded), these recent findings underline that the 
pathophysiology is not perfectly understood in patients with SAS.  
Oxygenation-sensitive cardiovascular magnetic resonance imaging (OS-CMR) is an 
emerging and promising technique that can investigate the oxygenation at the level of tissues or 
blood. This approach uses the paramagnetic properties of deoxygenated hemoglobin, also known 
as the blood oxygen level-dependent (BOLD) effect, as an endogenous contrast [7-9]. The signal 
intensity of tissue in BOLD- or OS-CMR images is inversely correlated with the concentration of 
deoxygenated hemoglobin, which is in turn a result of the oxygen supply-demand balance and 
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thus blood flow and blood volume [10]. Applied to the heart, OS-CMR has been shown to 
consistently and accurately detect changes in myocardial oxygenation in vivo [11]. This provides 
incremental information in coronary artery disease [12, 13] and allows for verifying changes in 
blood flow [14] and myocardial oxygenation, for example during stress-induced myocardial 
ischemia [15-19].  
Breathing maneuvers have been proposed as a physiological vasoactive stimulus leading 
to consistent myocardial signal intensity changes in oxygenation-sensitive MR images [8, 20-23]. 
Mostly related to changes in blood carbon dioxide (CO2), a breath-hold (leading to hypercapnia 
with a net increase of blood CO2) is an effective vasodilator, whereas hyperventilation with 
hypocapnia causes vasoconstriction [8, 20-22]. By combining these maneuvers, the achievable 
changes in pCO2 are increased, resulting in a more extended range in vascular resistance with 
greater changes in OS signal intensity  
Because of an abnormal coronary vascular response in patients with OSAS, we 
hypothesized that the coronary vascular response to hyperventilation and long breath-hold is 
diminished in patients with OSAS when compared to healthy volunteers, as reflected by changes 
in myocardial oxygenation during voluntary apnea following hyperventilation. 
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Methods 
Subjects 
Thirty patients with OSAS and 37 healthy volunteers were prospectively included in this single-
center study. Documented patient characteristics included cardiovascular risk factors and 
treatment by continuous positive airway pressure (CPAP).  
 All patients were referred to the Montreal Heart Institute with known OSAS as confirmed 
by polysomnography. Healthy participants were recruited by public advertisements and voluntary 
enrolment. Data of 19 healthy participants were already used in a previously published healthy 
control study [23].  
 
Exclusion criteria 
Participants with classical contra-indication for CMR imaging (e.g. pacemaker, implanted 
defibrillator, metal devices or implants, and known claustrophobia), severe HF, previous known 
myocardial infarct, or unstable coronary artery disease were excluded. Additional exclusion 
criteria for the healthy participants included smoking during the previous 6 months, other known 
cardiovascular or respiratory disease, or treatment with vasoactive medication.  
 
Experimental protocol 
The trial was performed in accordance with the Declaration of Helsinki. The study protocol was 
approved by the institutional ethics committee. All participants gave their signed informed 
consent for the study. 
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CMR 
Imaging was performed with a clinical 3T MRI system (MAGNETOM Skyra 3T; Siemens, 
Erlangen, Germany) using an 18-channel cardiac phased array coil. Images were obtained during 
breath-holds at comfortable end-expiration. LV function was assessed using an electrocardiogram 
(ECG) gated balanced steady-state free precession (SSFP) sequence (echo time/TE and repetition 
time/TR 1.43 ms and 3.3 ms, respectively; flip angle 65°; voxel dimensions 1.6x1.6x6.0 mm; 
matrix 192x120; bandwidth 962 Hz), covering the entire left ventricle by a short-axis stack or by 
six LV-centered radial long-axis slices with plus 3 short-axis views. OS-CMR images were 
acquired in one mid-ventricular short-axis slice using an ECG triggered SSFP sequence (TE/TR 
1.70 ms/3.4 ms; flip angle 35°; voxel dimensions 2.0x2.0x10.0 mm; matrix 192x120, bandwidth 
1302 Hz). Image acquisition was continuously repeated throughout the entire voluntary breath-
hold.  
The breathing maneuver (Fig. 1) was a combined hyperventilation/breath-hold in which 
participants breathed rapidly and deeply for 60 seconds aiming for a rate of approximately 30 
breaths/minute or more. This was followed by a maximal voluntary breath-hold performed at 
end-expiration. OS-CMR images were acquired continuously throughout the breath-hold. During 
hyperventilation, the patients were monitored through live video feed, and were instructed to 
change breathing depth and pace if the performance was insufficient. When participants indicated 
their need for inspiration by an alarm ball, image acquisition was stopped. Furthermore, the CMR 
images were simultaneously verified during the breath-hold to ensure compliance. This approach 
allows the investigation of pathophysiological mechanisms accurately. For instance, at the 
beginning of the breath-hold, we expect mostly vasodilatation without any desaturation, 
reflecting the high physiological adaptability. 
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Image analysis 
All images were analyzed using certified software (cvi42 version 4.1, Circle Cardiovascular 
Imaging, Calgary, AB, Canada). Analysis of left ventricular function was performed from 
epicardial and endocardial contours in diastolic and systolic images. For OS-CMR images, 
end-systolic images were used for analysis. The mean myocardial signal intensity (SI) in the 
OS-CMR images was automatically calculated after manual tracing of endocardial and epicardial 
contours.  SI was expressed as % change (∆SI[%]) using the first image of the breath-hold as the 
baseline and measured at 15 s, 30 s, 45 s, as well as at the end of the breath-hold. From the 
results, the maximum slope of the SI curve during the first 30 s was computed.  
 
Statistical analysis 
The sample size was estimated based on mean expected change of 15% with a standard deviation 
of 20%, aiming for 80% power. Continuous variables were assessed for normal distribution with 
the D’Agostino-Pearson test. Normally distributed variables are expressed as mean and standard 
deviation (SD), otherwise median and interquartile range (IQR) describe the variables with 
non-normal distribution. An independent t-test or a Mann-Whitney U test compared data between 
groups. OS-CMR results between the healthy control and OSAS group were assessed with a 
general linear model, using age as a covariate, to assess if age had a significant interaction at each 
time-point, using a Bonferroni multiple comparisons test if appropriate. For visualization of the 
response, SI during the breath-holds were fitted by a polynomial regression curve using the least-
squares method. Readings of 12 patients were replicated by a second independent reader and 
inter-observer reliability was assessed using a two-way intraclass correlation (ICC) test. Tests 
were performed with GraphPad Prism version 6.0 for mac (GraphPad Software, La Jolla, CA, 
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USA) and SPSS version 21 (SPSS, IBM, Armonk, NY, USA). Results were considered 
statistically significant with a p-value <0.05.  
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Results 
Population characteristics 
Twenty-nine patients with OSAS and 36 healthy volunteers successfully completed the study 
(Fig. 2, Table 1). One of the patients did not fulfill the predefined LVEF criterion (LVEF>35%) 
and one healthy volunteer withdrew from the examination due to claustrophobia (Fig. 2). The 
data from these two subjects were not included in the analysis. All other participants were able to 
complete the breathing maneuvers and no procedure was stopped.  
Group characteristics are described in Table 1. Patients with OSAS were significantly 
older than control subjects and had a higher body mass index (BMI). OSAS patients were 
followed mainly for symptoms not related to myocardial ischemia and stable coronary disease, 
but 83% also presented with at least one of the following co-morbidities: hypertension (55%), 
overweight with a BMI >30 kg/m2 (69%), dyslipidemia (48%), and coronary artery disease 
(24%). Sixty-six percent of the patients were currently treated with nocturnal CPAP and had been 
followed for OSAS for 9.8±7.1 years. LVEF and indexed myocardial mass were normal in both 
groups. Healthy volunteers had larger end-systolic and end-diastolic volumes (Table 1). 
 
Reproducibility of results in patients with OSAS  
A strong intraclass correlation coefficient (ICC) of 0.93 (95%CI: 0.90-0.95) indicated that the 
readers had a high degree of consistency in analyzing the images.  
 
Effect of prolonged apnea on myocardial signal intensity 
In both patients and healthy volunteers, myocardial oxygenation, as defined by changes of SI in 
OS-CMR, was significantly impacted by the breathing maneuver (Fig. 3). Non-linear best-fit 
regression curves of the change in SI over the breath-hold are presented in Figure 4.  Patients had 
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a delayed and attenuated response. On the other-hand, healthy volunteers had a rapid response 
from the beginning of the breath-hold, resulting in a greater slope of ∆SI[%] than the OSAS 
patients. At all three defined time-points during the breath-hold (15, 30, and 45 s), healthy 
participants had a significantly larger ∆SI[%] than OSAS patients (Fig. 4). By the end of the 
breath-hold in OSAS patients, SI decreased to 4.0±11.0%, whereas healthy volunteers maintained 
a higher SI (8.8±8.0%; p=0.03) by the time they needed to breathe. While at 15 and 30 s, age was 
not a significant factor; at the 45 s point near the end of the breath-hold, age did have a 
significant interaction (p=0.02). Yet, even when accounting for this, the difference in OS-CMR 
results between groups was significant (p=0.01). 
 
Effect of CPAP treatment 
OSAS patients without CPAP treatment (n=10) did not differ from healthy controls (Fig. 4b), 
whereas patients under CPAP (n=19) had a significantly attenuated mean oxygenation response 
at all time-points in comparison to healthy controls (15 s: 0.8±9.3 vs. 6.8±5.6; 30 s: 2.2±7.1 vs. 
9.8±6.7; 45 s: 4.8±2.1 vs. 11.3 ± 7.5, p<0.02). Furthermore, OSAS patients receiving CPAP 
treatment had a significantly lower slope of ∆SI[%], and a lower response at 30 s (2.2±7.1 vs. 
8.6±7.1, p=0.04) in comparison to non-CPAP treated OSAS patients.   
 
 
 
Discussion 
Our data show that there is a blunted coronary vascular response in patients with OSAS, 
especially in those under positive airway pressure therapy. Furthermore, our study shows that 
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oxygenation-sensitive CMR with breathing maneuvers is feasible in patients with cardiovascular 
or respiratory disease.  
In order to be feasible for most patients, the most important time-points are data collected 
within the first 30 s and the slope value assessing the initial oxygenation response. After a proper 
period of hyperventilation, 86% of SAS patients and 94% of the controls maintained the breath-
hold for 30 s, and all participants managed a breath-hold of at least 15 s. Of note, the attenuation 
of the coronary vascular/oxygenation response in patients with OSAS was already evident as 
early as 15 s after initiating a breath-hold following hyperventilation. This indicates a potential of 
this test to be used clinically, as it does not represent a significant challenge for patient 
compliance. The reduced vascular response does not support the hypothesis that repeated 
ischemic episodes lead to pre-conditioning and thus maintains vascular function and oxygenation.   
Patients with OSAS are known to suffer more frequently from co-morbidities, especially obesity 
[24]. This could be linked to higher oxidative stress [25-27], endothelial dysfunction [28-30], less 
nitric oxide production [31], and inflammation [32]. All of these pathophysiological aspects 
could contribute to a decreased myocardial adaptive response. Consistent with our findings, a 
study in 10 patients with hypertensive LV hypertrophy demonstrated an impaired ability to 
increase intra-myocardial oxygenation during vasodilatory stress [33].   
Most study participants were under treatment with CPAP, which may have improved their 
endothelial function [34-36]. In an observational study, CPAP treatment also significantly 
reduced cardiovascular event rates when compared to patients without CPAP [37]. In contrast, a 
randomized controlled study in 725 less severe patients failed to show a clinical benefit of CPAP 
on cardiovascular outcomes [38]. In our study, patients not on CPAP had a similar myocardial 
oxygenation response to healthy controls, whereas those on CPAP had a significantly reduced 
response. This may have been due to more severe and advanced disease and thus also more 
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severe microvascular disease of the group under CPAP therapy. However, the numbers of 
patients are small and CPAP modalities are various as well as the observance, preventing from 
concluding in the present study. Further works are needed to investigate this question. This 
paradoxical result should also be interpreted as suggesting adverse effects of the CPAP. The 
various modalities for the treatment will have to be taken into account in further studies, 
particularly because of the SERVE-HF study [6] suggesting that servo-ventilation could exert 
deleterious effects - but not the other modalities for CPAP treatment.  
 
Interestingly, whereas healthy volunteers had to breathe as soon as oxygenation signal 
started to decrease from the maximum value, OSAS patients could hold their breath until the 
oxygenation-related signal intensity decreased toward baseline values. This likely reflects a 
greater tolerance of the OSAS patients to hypercapnia and hypoxia.  
These results pave the way for further basic research to better understand the 
physiological adaptations to repetitive hypercapnia and hypoxia. OS-CMR also may offer a 
powerful approach for assessing the myocardial response to short periods of ischemia as shown 
in animal models.  
This new approach could address pathophysiological concerns such as those raised by the 
recent warnings in the SERVE-HF study [6]. Probably the pathophysiological mechanisms 
involved in cardiovascular disorders are not similar in patients with HF and predominantly 
central apneas when compared to patients without HF and predominantly obstructive apneas. 
Myocardial oxygenation response could be consistently compared in different groups of patients 
with various forms of SAS. In dedicated prospective trials, the impact of OSAS on the one hand, 
but on the other hand the impact of the CPAP as well as the various modalities of ventilations 
could be evaluated through these pathophysiological approaches. We could imagine that the most 
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“physiological” response as regards myocardial response during the breathing manoeuvers could 
be considered as a valuable exploratory endpoint. 
 
Limitations 
This study was performed in a relatively small patient population. The confirmation of our 
findings in a larger population but also in other clinical settings is now warranted. Indeed, the 
confirmation of our results in animal models has just been recently provided [22] as well as 
application in healthy volunteers [23].  
Confounders such as sex, age, body weight, co-existing coronary artery disease, arterial 
hypertension, and atrial fibrillation may have impacted our results. Indeed, as the populations 
(healthy volunteers versus patients with OSAS) are not similar, the impact of biases cannot be 
excluded. Nevertheless, patients with OSAS are well-known to present also more comorbidities. 
Because of the small sample size, we cannot take into account all the potential biases. 
Finally, results regarding CPAP are surprising and we present above some likely 
explanations. One limitation is also the lack of details on the observance, previous treatments, 
type of CPAP, modalities of ventilations… 
  
 
Conclusion 
The myocardial vascular response to combined breathing maneuvers of hyperventilation followed 
by voluntary apnea is blunted in patients with obstructive sleep apnea. Clinical studies should 
now further define the clinical role of oxygenation-sensitive CMR in patients with respiratory 
disorders. 
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Figure Legends 
 
Figure 1 Schematic of the combined breathing maneuver. Participants performed 60 s of 
hyperventilation aiming for a respiratory rate of 30 breaths/min, followed immediately by a long 
breath-hold. The breath-hold was continuously imaged with oxygenation-sensitive cardiovascular 
magnetic resonance imaging. 
OSAS, obstructive sleep apnea syndrome. 
Figure 2 Flow chart of patients. 
CMR, cardiovascular magnetic resonance imaging.  
 
Figure 3 Color maps of signal intensity changes in oxygenation-sensitive cardiovascular 
magnetic resonance images in a patient with obstructive sleep apnea syndrome (OSAS) and a 
healthy subject. Subtraction image of signal intensity changes from baseline to the three time 
points within the breath-hold (15 s, 30 s, and 45s ). The signal intensity increase is more 
pronounced in the healthy subject (top row) as compared to the patient with OSAS (bottom row). 
 
Figure 4 Change in myocardial oxygenation during long breath-holds after 
hyperventilation. (A) Non-linear regression curves (95% confidence bars) of the average signal 
intensity (SI) change in oxygenation-sensitive cardiovascular magnetic resonance images during 
a maximal voluntary breath-hold, performed immediately after a 60-second period of 
hyperventilation in 29 patients with obstructive sleep apnea syndrome (OSAS) (blue) and 36 
healthy volunteers (green). The overall response is blunted in patients and the signal intensity is 
significantly different between the groups at the 15 s, 30 s, and 45 s time-points (square: mean ± 
SD, †p<0.05 between healthy and OSAS results at each time-point). (B) Comparison of 
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oxygenation changes within the OSAS patient group, divided into patients with (n=19, black) and 
patients without (n=10, grey) Continuous positive airway pressure (CPAP) treatment. Patients 
with CPAP treatment show a reduced vascular response to the breathing maneuver (‡p<0.05 
between healthy and OSAS patients on CPAP, §p<0.05 between treatment with and without 
CPAP treatment). (C) Mean±SD (n) change in oxygenation signal intensity from baseline at 
multiple time-points during the breathing maneuver in both groups (*p<0.05 for change from 
baseline within the breath-hold). At all time points, OSAS patients showed a blunted response.  
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